中国肝癌发病趋势和一级预防

陈建国

中国肝癌发病趋势和一级预防

陈建国

启东肝癌防治研究所

详细信息

中图分类号: R735.7
计量
- 文章访问数: 3680
- HTML全文浏览量: 29
- PDF下载量: 915
- 被引次数: 0
出版历程
- 出版日期: 2012-04-20

Trends in the incidence of liver cancer and its primary prevention in China

Chen JianGuo

摘要

摘要: <正>原发性肝癌是全球最常见的癌症,发病率有特别大的地理变异,约82%的病例发生在发展中(欠发达)国家,特别是东亚、北亚和南亚,撒哈拉南部的非洲国家;而中亚和西亚,北欧和东欧是肝癌的低发区。全球原发性肝癌发病率位居癌症发病之第6位(男性第5位,女性第7位),由于肝癌有较高的致死率,因此其死亡率位居癌症死亡之第3位(男性第2位,女性第6位)。在发展中国家,男女性肝癌的发病率分
- 肝肿瘤 /
- 一级预防
- liver neoplasms /
- primary prevention

HTML全文

参考文献(39)

[1]Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics, 2002[J].CA Cancer J Clin, 2005, 55 (2) :74-108.

[2]Jemal A, Bray F, Center MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.

[3]IARC.GLOBOCAN 2008, Cancer incidence and mortalityworldwide in 2008[DB/OL].http://globocan.iarc.fr, 2011-8-22.

[4]Alam N, Robotin M, Baker D.Epidemiology of primary livercancer[J].Cancer Forum, 2009, 33 (2) :88-92.

[5]Hattori M, Fujita Manabu, Ito Y, et al.Use of a population-based cancer registry to calculate twenty-year trends incancer incidence and mortality in Fukui Prefecture[J].J Epi-demiol, 2010, 20 (3) :244-252.

[6]Stuver S, Trichopoulos D.Cancer of the liver and biliary tract[Chapter 12].In:Adami[C]//HO, New York:Oxford Uni-versity Press, 2008:308-332.

[7]陈建国, 张思维, 陈万青.中国2004-2005年全国死因回顾抽样调查肝癌死亡率分析[J].中华预防医学杂志, 2010, 44 (5) :383-389.

[8]Chen JG, Zhang SW.Liver cancer epidemic in China:past, pres-ent and future[J].Semin Cancer Biol, 2011, 21 (1) :59-69.

[9]陈建国, 朱健, 张永辉, 等.启东1973至2002年肝癌发病率长期趋势的评价[J].中华医学杂志, 2005, 85 (43) :3052-3056.

[10]韦忠亮, 梁任祥, 汪凯波, 等.扶绥县1974-2003年肝癌发病率变化趋势分析[J].中国肿瘤, 2007, 16 (9) :679-680.

[11]陈建国, 陆建华, 朱源荣, 等.乙型肝炎病毒感染与肝癌发生的31年随访研究[J].中华流行病学杂志, 2010, 31 (7) :721-726.

[12]Sun Z, Lu P, Gail MH, et al.Increased risk of hepatocellularcarcinoma in male hepatitis B surface antigen carriers withchronic hepatitis who have detectable urinary aflatoxin me-tabolite M1[J].Hepatology, 1999, 30 (2) :379-383.

[13]Qian GS, Ross RK, Yu MC, et al.A follow-up study of uri-nary markers of aflatoxin exposure and liver cancer risk inShanghai, People's Republic of China[J].Cancer EpidemiolBiomarkers Prev, 1994, 3 (1) :3-10.

[14]Wang LY, Hatch M, Chen C J, et al.Aflatoxin exposure andrisk of hepatocellular carcinoma in Taiwan[J].Int J Cancer, 1996, 67 (5) :620-625.

[15]El-Serag HB, Rudolph KL.Hepatocellular carcinoma:epi-demiology and molecular carcinogenesis[J].Gastroenterol-ogy, 2007, 132 (7) :2557-2576.

[16]Tanaka M, Katayama F, Kato H, et al.Hepatitis B and C vi-rus infection and hepatocellular carcinoma in China:a reviewof epidemiology and control measures[J].J Epidemiol, 2011, 21 (6) :401-416.

[17]Lu J, Zhou YD, Lin XJ, et al.General epidemiological pa-rameters of viral hepatitis A, B, C, and E in six regions ofChina:a cross-sectional study in 2007[J].PLoS One, 2009, 4 (12) :e8467.

[18]Yuan J M, Govindarajan S, Henderson BE, et al.Low preva-lence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperen-demic region for HCC in the People's Republic of China[J].Br J Cancer, 1996, 74 (3) :491-493.

[19]Ming L, Thorgeirsson SS, Gail MH, et al.Dominant role ofhepatitis B virus and cofactor role of aflatoxin in hepatocarci-nogenesis in Qidong, China[J].Hepatology, 2002, 36 (5) :1214-1220.

[20]Szyma nska K, Chen JG, Cui Y, et al.TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China[J].Cancer Epidemiol Biomarkers Prev, 2009, 18 (5) :1638-1643.

[21]谭盛葵, 仇小强, 余红平, 等.广西肝癌高发区原发性肝癌危险因素病因分值及其交互效应[J].中华预防医学杂志, 2008, 42 (3) :169-172.

[22]Kwon SY, Lee CH.Epidemiology and prevention of hepatitis B virus infection[J].Korean J Hepatol, 2011, 17 (2) :87-95.

[23]Centers for Disease Control, Prevention.CDC[J].MMWR Morb Mortal Wkly Rep, 2007, 56 (18) :441-445.

[24] 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :I-XVI.

[25]Ni Y H, Chen D S.Hepatitis B vaccination in children:the Taiwan experience[J].Pathol Biol (Paris) , 2010, 58 (4) :296-300.

[26]Wu Q, Zhuang GH, Wang XL, et al.Antibody levels and im-mune memory23years after primary plasma-derived hepa-titis B vaccination:results of a randomized placebo-con-trolled trial cohort from China where endemicity is high[J].Vaccine, 2011, 29 (12) :2302-2307.

[27]Zhu CL, Liu P, Chen TY, et al.Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepati-tis B vaccination[J].Vaccine, 2011, 29 (44) :7835-7841.

[28]陈建国.肝癌病因和预防研究的新进展[J]. (中华) 肿瘤防治杂志, 2003, 10 (11) :1121-1125.

[29]Kensler KW, Qian G S, Chen J G, et al.Translational strate-gies for Cancer prevention in liver[J].Nat Rev Cancer, 2003, 3 (5) :321-329.

[30]Wang J S, Shen X, He X, et al.Protective alterations in phase1and2metabolism of aflatoxin B1by oltipraz in resi-dents of Qidong, People's Republic of China[J].J Natl Cancer Inst, 1999, 91 (4) :347-354.

[31]Kensler TW, Gange SJ, Egner PA, et al.Predictive value of molecular dosimetry:individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer[J].Cancer Epidemiol Biomarkers Prev, 1997, 6 (8) :603-610.

[32]Castro DJ, L o..hr CV, Fischer KA, et al.Identifying effica-cious approaches to chemoprevention with chlorophyllin, pu-rified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesis[J].Carcinogenesis, 2009, 30 (2) :315-320.

[33]Simonich MT, Mcquistan T, Jubert C, et al.Low-dose dietary chlorophyll inhibits multi-organ carcinogenesis in the rainbow trout[J].Food Chem Toxicol, 2008, 46 (3) :1014-1024.

[34]Egner PA, Wang JB, Zhu YR, et al.Chlorophyllin interven-tion reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer[J].Proc Natl Acad Sci U S A, 2001, 98 (25) :14601-14606.

[35]Fiala JL, Egner PA, Wiriyachan N, et al.Sulforaphane-me-diated reduction of aflatoxin B 1-N 7-guanine in rat liver DNA:impacts of strain and sex[J].Toxicol Sci, 2011, 121 (1) :57-62.

[36]沈莲清, 苏光耀, 王奎武.西兰花种子中硫苷酶解产物萝卜硫素的提纯与抗肿瘤的体外试验研究[J].中国食品学报, 2008, 8 (5) :15-21.

[37]Kensler TW, Chen JG, Egner PA, et al.Effects of glucosi-nolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clini-cal trial in He Zuo township, Qidong, People's Republic of China[J].Cancer Epidemiol Biomarkers Prev, 2005, 14 (11 Pt1) :2605-2613.

[38]Kensler TW, Ng D, Carmella SG, et al.Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, Chi-na[J].Carcinogenesis, 2012, 33 (1) :101-107.

[39]Egner PA, Chen JG, Wang JB, et al.Bioavailability of sul-foraphane from two broccoli sprout beverages:results of a short-term, cross-over clinical trial in Qidong, China[J].Cancer Prev Res (Phila) , 2011, 4 (3) :384-395.

施引文献

资源附件(0)

访问统计